Categories: News

VIVO Cannabis(TM) Supports Patients and Hope Community During BC Flooding

Toronto, Ontario–(Newsfile Corp. – November 19, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited (“Canna Farms”) and ABcann Medicinals Inc., today provided an update on the recent flooding situation affecting Southern British Columbia.

VIVO’s facility in Hope, BC is at the epicentre of the Trans Canada Highway’s damage. Though the Hope facility is directly beside the Fraser River, it has not sustained any physical damage, and the safety of VIVO’s employees and medical patients remains the highest priority. At this time, several of our team members, who have been displaced from their homes in Chilliwack and Yale, are sheltering with friends and family in Hope.

To support the local community and to ensure continued access for our patients’ medical cannabis needs, VIVO has worked closely with Purolator’s Mission Critical team to arrange a helicopter that flew from Vancouver’s airport to the Canna Farms Hope facility yesterday, November 18th. On the inbound trip from Vancouver the helicopter brought food and supplies to the Hope community and to the Canna Farms facility, and on the outbound trip Canna Farms shipped hundreds of patients’ medical orders to the Purolator and Canada Post depots in Vancouver. VIVO’s Canna Farms team is working with local organizers in Hope, to provide needed support and supplies for those sheltering at the local high school and church.



PICTURED: 
Pilots and Canna Farms Logistics Team ready to receive supplies and ship patient orders. (NOV 18, 2021)

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/3063/104498_picture1vivo.jpg

“As one of the biggest employers in the town of Hope we are committed to helping in every way we can toward ensuring the safety and wellbeing of the community. At the same time we remain committed to the hundreds of Canna Farms medical patients who rely on our products for their medical needs,” commented Ray Laflamme, Canna Farms’ Co-Founder and VIVO’s Chief Executive Officer. “We’d like to give special thanks to the members of our Canna Farms Hope team who have gone above and beyond to ensure the community and patients’ needs are met, and appreciate all the warm emails, calls, and messages; we are thankful for your support.”

Patients with questions about the status of their orders may contact VIVO’s Customer Care Team at 1 (855) 882-0988 or care@vivocannabis.com.

About VIVO Cannabis™

VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of medical, health and wellness brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, and Lumina™. Harvest Medicine™, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com.

For further information:
VIVO Investor Relations
+1 416-848-9839
ir@vivocannabis.com

Instagram: https://www.instagram.com/vivo_cannabis/
Facebook: https://www.facebook.com/vivocanna/ 
Twitter: https://twitter.com/vivo_cannabis
LinkedIn: https://www.linkedin.com/company/vivo-cannabis-inc/

Disclaimer for Forward-Looking Information

Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward‐looking statements. No assurance can be given that any of the events anticipated by the forward‐looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully along with the more extensive risk factors included in the Company’s most recent management’s discussion and analysis available on SEDAR, in evaluating the forward‐looking statements contained in this news release and are cautioned not to place undue reliance on such forward‐looking statements, which are qualified in their entirety by these cautionary statements. The forward‐looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward‐looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104498

Staff

Recent Posts

Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

58 minutes ago

FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers

NEW CANAAN, Conn., Dec. 22, 2025 /PRNewswire/ -- FlyteHealth, a national leader in integrated cardio-kidney-metabolic care,…

58 minutes ago

10 Days, 10 Ways to Spend FSA (Flexible Spending Account) Funds Before the December 31 Use-It-or-Lose-It Deadline, from FSA Store®

The clock is ticking on 2025 FSA funds, and as the use-it-or-lose-it deadline approaches, FSA…

58 minutes ago

TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year

TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking…

58 minutes ago

NUCALM CELEBRATES RECORD-BREAKING DECEMBER WITH OVER 2 BILLION MINUTES USED AND LARGEST LIVE EVENT ACTIVATION EVER

Tony Robbins' "Date with Destiny" Event Drives Unprecedented Engagement with NuCalm TechnologyPALM BEACH, Fla., Dec.…

58 minutes ago

Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints

New Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning…

58 minutes ago